| PD‐1/PD‐L1 immune checkpoint: potential target for cancer therapy FK Dermani, P Samadi, G Rahmani, AK Kohlan, R Najafi Journal of cellular physiology 234 (2), 1313-1325, 2019 | 408 | 2019 |
| The clinical significance of histone deacetylase-8 in human breast cancer G Rahmani, S Sameri, N Abbasi, M Abdi, R Najafi Pathology-Research and Practice 220, 153396, 2021 | 13 | 2021 |
| 1/PD-L1 immune checkpoint: Potential target for cancer therapy., 2019, 234 FK Dermani, P Samadi, G Rahmani, AK Kohlan, RN PD DOI: https://doi. org/10.1002/jcp 27172, 1313-1325, 0 | 7 | |
| Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study G Rahmani, MR Moloudi, R Amini, K Rahimi, F Fathi, M Abdi, R Najafi Life sciences 311, 121156, 2022 | 3 | 2022 |
| PD-1/PD-L1 inhibitor 2 FK Dermani, P Samadi, G Rahmani, AK Kohlan, R Najafi | | |
Rezvan Najafihamadan university of medical sciences在 umsha.ac.ir 的电子邮件经过验证
